Elevance Health Inc.
Price Action
Technical Summary
STAGE 2 UPTRENDElevance Health Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is moderate (RS Rating: 75), indicating performance broadly in line with the market. Earnings contraction of 17% provides fundamental context to the price action. Momentum will need to be maintained above the 50-day moving average to sustain this leadership phase.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $401.11 | +4.42% | ABOVE |
| 50 SMA | $391.85 | +6.89% | ABOVE |
| 100 SMA | $350.64 | +19.45% | ABOVE |
| 150 SMA | $350.60 | +19.47% | ABOVE |
| 200 SMA | $346.03 | +21.04% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ELV in an uptrend right now?
ELV has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, ELV is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is ELV overbought or oversold?
ELV's RSI (14) is 57. The stock is in neutral territory, neither overbought nor oversold.
Is ELV outperforming the market?
ELV has a Relative Strength (RS) Rating of 75 out of 99. ELV is performing about average compared to the market.
Where is ELV in its 52-week range?
ELV is trading at $418.85, which is 98% of its 52-week high ($427.19) and 95% above its 52-week low ($273.71).
How volatile is ELV?
ELV has a Beta of 0.36 and 52-week volatility of 38%. It's less volatile than the S&P 500 - generally more stable.